Leukocare

Leukocare is a science-driven formulation development partner specializing in biologics, including monoclonal antibodies, viral vectors, vaccines, and other complex biologics. They support biotech and pharmaceutical companies from early development through life-cycle management of marketed products. Their approach combines deep formulation expertise with advanced bioinformatic and biostatistic approaches for data-driven decision-making to systematically address stability and delivery challenges. Rather than applying standard platform formulations, they tailor strategies to the specific molecular and program needs of each project.

Their unique technologies integrate experimental data with computational tools to better understand degradation mechanisms, excipients in the desired route of administration, and formulation risks early on. This enables faster, more informed development decisions, reduces trial-and-error, and supports efficient progression toward clinical and commercial milestones. They work as an extension of their clients’ CMC teams, valuing close collaboration, scientific transparency, and flexibility. Headquartered in Germany, they operate with 50 people, a strong international footprint, and a track record of successfully advancing challenging biologic drug products toward the clinic. Leukocare’s tagline is: “Leukocare, Smart formulation for better biologics.” 

quick proposal

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.